Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-03

Clinical Trial Update: Tibolone Endometrium Study (Study 32972)(P06470) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for tibolone endometrium study in postmenopausal women. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tibolone (tibolone)

Snippet

Sponsor: Organon and Co | Conditions: Postmenopausal Women | Phase 3 | Status: COMPLETED